Sterile compounded preparation to support corneal epithelial repair.
Specialized therapeutic option for refractory ocular surface conditions.
Topical insulin is a compounded ophthalmic preparation used for selected ocular surface diseases characterized by impaired epithelial healing. The cornea features specific receptors through which insulin promotes tissue regeneration. It is not an eye drop "for diabetes" nor a generic treatment for common dry eye, but a targeted re-epithelialization support prescribed by a specialist.
Clinical applications strictly evaluated by the Ophthalmologist.
Topical insulin is assessed when conventional therapies fail to heal the cornea:
Reduced corneal sensitivity and impaired tissue self-repair.
Refractory corneal ulcers (PED) that fail to close.
Structural ocular surface alterations in metabolic profiles.
Defect in epithelial adhesion to the basement membrane.
Surface lesions showing no signs of spontaneous healing.
Post-acute regenerative phase following thermal/chemical damage.
Epithelial suffering secondary to prolonged abuse of preserved drops.
Recent systematic reviews (2025-2026) highlight that topical insulin promotes high re-epithelialization rates. While promising, it remains an emerging therapy requiring tailored protocols.
Binds to corneal receptors promoting cellular migration.
Acts on signaling pathways regulating epithelial integrity.
Topical dosages studied have shown no clinical impact on blood glucose.
In severe keratopathies, another high-profile regenerative option evaluated by specialists is autologous serum eye drops, a blood-derived therapy rich in growth factors.
Discover Autologous Serum →What to know about prescriptions, pharmacy preparation, and home care.
Strictly requires an ophthalmologist's prescription; not over-the-counter.
Prepared exclusively by authorized compounding pharmacies with sterile facilities.
Often requires refrigeration; always follow the pharmacist's label instructions.
May cause transient burning; immediately report increased pain or photophobia.
Clarifying the real medical use of ophthalmic insulin:
| Topic | Myth (Incorrect) | Medical Fact (Reality) |
|---|---|---|
| Purpose | Cures systemic diabetes through the eyes | Acts locally to regenerate the corneal epithelium |
| Availability | Can be bought ready-made over the counter | It is a sterile custom-compounded medication |
| Universal Use | Replaces artificial tears for mild dry eye | Reserved for severe and refractory corneal damage |
| Glycemic Effects | Alters blood glucose levels systemically | No relevant systemic effects emerge from clinical data |
Dosages (U/mL) and treatment duration are individually tailored by the specialist.
An epithelial defect is not merely "intense dry eye". It indicates a vulnerable surface that may conceal neuro-inflammation, eyelid alterations, or systemic imbalances. Topical insulin provides targeted regenerative support, but long-term success lies within Systemic Ophthalmology: assessing the patient's biological terrain, immune axis, and root causes.
Deontological Notice: Information is for educational purposes. Insulin eye drops represent an emerging compounded therapeutic option, not a universal standard cure. Requires clinical diagnosis.